A closed-loop platform for hemodynamic conditioning.
Hemokinetix integrates postural transition, lower-limb vascular compression, and respiratory pacing under ECG-derived biofeedback. The device is in development.
Three synchronized inputs. One closed loop.
The device integrates three physiological stimuli in real-time coordination, with continuous ECG-derived feedback that closes the loop. Each input is mechanistically distinct; together they target the integrated autonomic and hemodynamic response.
Current development state.
Hemokinetix is in pre-market development. The information below reflects current state and is subject to change.
Twenty-five years at the intersection of autonomic physiology, respiratory mechanics, and biofeedback.
Noah McKenna is the founder and inventor of Hemokinetix. The device emerged from 25 years of clinical and research work at the intersection of autonomic physiology, respiratory mechanics, and heart rate variability biofeedback.
Noah holds an M.Sc. and is certified as a yoga therapist (C-IAYT) and experienced registered yoga teacher (E-RYT 500), with a research focus on resonant frequency breathing and vagal tone restoration. Prior to founding Hemokinetix, he developed clinical training programs in HRV biofeedback for licensed practitioners.
He leads Hemokinetix from concept through regulatory submission, with deep involvement in patent strategy, device design, and clinical protocol development.
Selective inbound. Considered response.
Hemokinetix is currently engaging selectively with medical device investors and regulatory advisors. We respond to qualified inquiries within five business days.
For seed and Series A medical device investors. Brief overview returned by reply; technical materials under mutual NDA.
For FDA-experienced regulatory, clinical, and quality advisors. Please include relevant clearance experience.